Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor α/γ agonist on glucose uptake

Author： Hu X. Feng Y. Liu X. Zhao X.-F. Yu J.-H. Yang Y.-S. Sydow-Bäckman M. Hörling J. Zierath J. Leng Y.

ISSN： 0012-186X

Source： Diabetologia, Vol.50, Iss.5, 2007-05, pp. : 1048-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju Lee Yong Chul

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

By Bajaj M. Suraamornkul S. Hardies L. Glass L. Musi N. DeFronzo R.

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1723-1731

Springer Publishing Company

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria

By Yilmaz Mahmut Sonmez Alper Caglar Kayser Gok Deniz Eyileten Tayfun Yenicesu Müjdat Acikel Cengizhan Bingol Necati Kilic Selim Oguz Yusuf Vural Abdulgaffar

Endocrine Journal, Vol. 25, Iss. 3, 2004-12 ,pp. : 207-214

Humana Press, Inc

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: acute effect of fatty acids

By Hoeks J. Hesselink M. Russell A. Mensink M. Saris W. Mensink R. Schrauwen P.

Diabetologia, Vol. 49, Iss. 10, 2006-10 ,pp. : 2419-2426

Springer Publishing Company

Access to resources Recommend Favorite